Endocrinology News and Research

Latest Endocrinology News and Research

Dynamic Response Group to start national media campaign for its diabetic supply products to the Hispanic market

Dynamic Response Group, Inc. announced today on October 19, 2009 it will start the national media campaign to roll-out its Medico Express diabetic supply products to the Hispanic market.

15 Oct 2009

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K. Shinseki decided to establish a service-connection for Vietnam Veterans with three specific illnesses based on the latest evidence of an association with the herbicides referred to as Agent Orange.

15 Oct 2009

New non-invasive technology to measure glucose levels in the human eye

New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc.

14 Oct 2009

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.

14 Oct 2009

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Diabetes care is undergoing a paradigm shift in which insulin is being prescribed earlier, for more conditions, in order to delay the onset of full-blown disease, according to a study released today by Scientia Advisors.

14 Oct 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species -- mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

State-level education policy essential to reverse childhood obesity

The new issue of The State Education Standard, the journal of the National Association of State Boards of Education (NASBE), examines how education policymakers can best address childhood obesity in school settings.

14 Oct 2009

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

According to a new report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $12.8 billion in 2008 to $17.8 billion by 2014.

14 Oct 2009

T.S. Wiley to lecture on the latest advances in anti-aging medicine

Wiley Systems™, Inc. announces that internationally acclaimed Author T.S. Wiley will be lecturing at the second annual European Congress on Anti-Aging & Aesthetic Medicine (ECAAAM) at the Congress Centre, Mainz, near Frankfurt, October 15-17, 2009. Wiley will give two lectures among other international experts presenting the latest advances in anti-aging medicine.

14 Oct 2009

Increase in adiponectin hormone levels protects against sepsis-related mortality

A hormone naturally found in the fat that surrounds the abdominal organs for the first time has been linked to death related to sepsis, surgeons reported at the 2009 Clinical Congress of the American College of Surgeons. A study exhibited at the conference showed that low levels of the hormone adiponectin placed animals at a profoundly high risk of death from a septic insult.

14 Oct 2009

National study shows people who work after retiring experience fewer major diseases

Retirees who transition from full-time work into a temporary or part-time job experience fewer major diseases and are able to function better day-to-day than people who stop working altogether, according to a national study. And the findings were significant even after controlling for people's physical and mental health before retirement.

14 Oct 2009

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

Galapagos NV announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to incorporate the development of new therapies for atherosclerosis.

14 Oct 2009

National Vaccine Information Center to launch a research fundraising campaign

At the Oct. 2-4, 2009 Fourth International Public Conference on Vaccination sponsored by the non-profit National Vaccine Information Center in Reston, VA, 700 citizens from 44 states and 11 nations raised more than $100,000 to launch an international scientific research fundraising campaign to investigate health differences between vaccinated and unvaccinated children and identify those at risk for suffering vaccine injury.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.

14 Oct 2009

Social networking sites can empower consumers to make informed decisions and improve quality of life

Can social networking sites help people make wise health decisions? A new study in the Journal of Consumer Research says it depend on people's willingness to take action on the information they gain from the sites.

14 Oct 2009

Market Street's initiative to combat cold and flu season

As a complimentary service, Market Street pharmacies are expanding the grocer’s whole-health commitment to its guests by offering free antibiotics and prenatal vitamins to North Texans to help weather the cold and flu season through its “Free to Feel Better” program. Additionally, Market Street’s new partnership with Dallas-based MedicalEdge has transformed the Living Well ExpressCare Centers into more than just walk-in clinics.

14 Oct 2009

Kaiser Permanente receives $54 million grant from NIH to conduct health research

14 Oct 2009

Endocrinology News and Research

Latest Endocrinology News and Research

Dynamic Response Group to start national media campaign for its diabetic supply products to the Hispanic market

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

New non-invasive technology to measure glucose levels in the human eye

Integrated Diagnostics launched to develop diagnostic tools and innovative biomarkers

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Brain researcher finds how the epilepsy and pain drug works

State-level education policy essential to reverse childhood obesity

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

T.S. Wiley to lecture on the latest advances in anti-aging medicine

Increase in adiponectin hormone levels protects against sepsis-related mortality

National study shows people who work after retiring experience fewer major diseases

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

National Vaccine Information Center to launch a research fundraising campaign

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

American Recovery and Reinvestment Act funds to support research in numerous health areas

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Social networking sites can empower consumers to make informed decisions and improve quality of life

Market Street's initiative to combat cold and flu season

Kaiser Permanente receives $54 million grant from NIH to conduct health research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Endocrinology News and Research

Latest Endocrinology News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in